Text: H.R.3796 — 104th Congress (1995-1996)All Information (Except Text)

There is one version of the bill.

Text available as:

  • TXT
  • PDF (PDF provides a complete and accurate display of this text.) Tip?

Shown Here:
Introduced in House (07/11/1996)

 
[Congressional Bills 104th Congress]
[From the U.S. Government Printing Office]
[H.R. 3796 Introduced in House (IH)]






104th CONGRESS
  2d Session
                                H. R. 3796

   To amend the Public Health Service Act to provide for research to 
 determine the extent to which the presence of dioxin in tampons poses 
                       any health risks to women.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 11, 1996

   Mrs. Maloney (for herself, Ms. Brown of Florida, Mr. Dellums, Mr. 
 Foglietta, Mr. Frost, Mr. Jacobs, Ms. Eddie Bernice Johnson of Texas, 
  Mr. Sanders, Mr. Thompson, Mr. Towns, Mr. Traficant, and Mr. Yates) 
 introduced the following bill; which was referred to the Committee on 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
   To amend the Public Health Service Act to provide for research to 
 determine the extent to which the presence of dioxin in tampons poses 
                       any health risks to women.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Women's Health and Dioxin Act of 
1996''.

SEC. 2. OFFICE OF RESEARCH ON WOMEN'S HEALTH; ESTABLISHMENT OF PROGRAM 
              FOR RESEARCH REGARDING PRESENCE OF DIOXIN IN TAMPONS.

    Part F of title IV of the Public Health Service Act (42 U.S.C. 287d 
et seq.) is amended by adding at the end the following section:

``SEC. 486C. CERTAIN PROJECTS REGARDING WOMEN'S HEALTH.

    ``The Director of NIH, in collaboration with the Director of the 
Office, shall provide for the conduct or support of research to 
determine the extent to which the presence of dioxin in tampons poses 
any health risks to women, including risks relating to cervical 
cancer.''.
                                 <all>

Share This